ImmunoCult™ Human CD3/CD28 T Cell Activator
-
ImmunoCult™ Human CD3/CD28 T Cell Activator -
Label for ImmunoCult™ Human CD3/CD28 T Cell Activator
More Views
Overview
This product is designed for cell therapy research applications following the recommendations of USP<1043> on Ancillary Materials, and we can currently work with you to qualify this reagent under an approved investigational new drug (IND) or clinical trial application (CTA).
This product aims to be developed as a cGMP-grade reagent for cellular therapy research. Learn more at www.stemcell.com/t-cell-therapy
• Provides a gentle activation stimulus that maintains high viability of activated and expanded T cells
• Highly stable, filter-sterilized soluble reagent
• Anti-human CD28 monospecific tetrameric antibody complex
Related Products
-
Human Peripheral Blood Pan-T Cells, Frozen
Primary human cells, frozen -
ImmunoCult™ Human CD3/CD28/CD2 T Cell Activator
Human T cell activation and expansion reagent -
ImmunoCult™-XF T Cell Expansion Medium
Serum-free and xeno-free medium for the expansion of human T cells -
EasySep™ Human T Cell Isolation Kit
8-Minute cell isolation kit using immunomagnetic negative selection
Scientific Resources
Product Documentation
Educational Materials
(12)
Product Applications
This product is designed for use in the following research area(s) as part of the highlighted workflow stage(s). Explore these workflows to learn more about the other products we offer to support each research area.
Data and Publications
Data
Figure 1. Activated Morphology of Human T Cells Stimulated With ImmunoCult™ Human CD3/CD28 T Cell Activator
Image of human T cells isolated using the EasySep™ Human T Cell Isolation Kit (Catalog #17951), stimulated with ImmunoCult™ Human CD3/CD28 T Cell Activator, and cultured in ImmunoCult™-XF T Cell Expansion Medium (Catalog # 10981).
Figure 2. Activation of EasySep™-isolated Human T Cells stimulated With ImmunoCult™ Human CD3/CD28 T Cell Activator
EasySep™-isolated human T cells were stimulated with ImmunoCult™ Human CD3/CD28 T Cell Activator and cultured in ImmunoCult™-XF T Cell Expansion Medium. Activation of viable CD3+ T cells was assessed by CD25 expression using flow cytometry. On day 0, the frequency of CD25 positive cells was (A) 5.6 ± 2.4% (mean ± SD). Following 3 days of culture, the frequency of CD25 positive cells was (B) 75.4 ± 13.8% (mean ± SD) when stimulated with ImmunoCult™ Human CD3/CD28 T Cell Activator.